Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The news center now features recent October 2026 announcements, including FDA approval of a SKYRIZI Crohn’s disease regimen and Phase 3 trial results for lutikizumab. Older news items and social posts have been replaced by newer updates.
    Difference
    9%
    Check dated 2026-10-24T11:09:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The News Center now features October 2026 announcements on SKYRIZI and RINVOQ outcomes in inflammatory bowel disease, including Phase 3 Crohn’s disease findings, alongside related social posts about conference research. Older news headlines and social posts have been replaced.
    Difference
    10%
    Check dated 2026-10-17T13:11:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The news feed now features AbbVie’s FDA Breakthrough Therapy Designations for an investigational treatment in colorectal and non-small cell lung cancers, along with Phase 3 lymphoma results announced with Genmab. Several earlier news items and social media updates have been replaced by newer posts.
    Difference
    9%
    Check dated 2026-10-10T12:49:37.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The news feed now features October announcements, including a federal 340B pilot, RINVOQ vitiligo data, and an upcoming earnings call, alongside new research and company updates. Older September headlines and social posts have been replaced by more recent content.
    Difference
    10%
    Check dated 2026-10-03T14:06:58.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The News Center gained new posts on September 22, 2026, including AbbVie’s participation in a USTR investigation, Allergan Aesthetics’ AA Signature launch with SKIN360, and European Commission approval of Rinvoq for pediatric JIA, while several older Real-world Data/IMS-related items were removed, indicating a feed refresh and content cleanup.
    Difference
    11%
    Check dated 2026-09-26T15:57:23.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    New News Center items were added, including real-world data on VRAYLAR at Psych Congress 2026, Phase 3 etentamig results for multiple myeloma at the IMS meeting, and Allergan Aesthetics data. Older posts and content blocks were removed, refining the lineup of featured news on the page.
    Difference
    10%
    Check dated 2026-09-19T22:05:20.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.